Skip to content

Alveolar Macrophage ImmuNOmetabolism study

Alveolar Macrophage ImmuNOmetabolism study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON29138
Enrollment
20
Registered
2021-08-03
Start date
2021-06-09
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia, pulmonary diseases

Interventions

Bronchoscopy, phlebotomy

Sponsors

AMC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • 18-60 years of age • non-smoking, or ex-smoking (=2 years ago) • no respiratory diagnosis of asthma or COPD • no history of bronchiectasis, lung cancer, pneumothorax or other significant respiratory disease. • no history of bleeding disorder • not using anti-inflammatory and/or anticoagulant medication • no major comorbidities • BMI 17-30 kg.m2

Exclusion criteria

Exclusion criteria: Individuals who are deemed immunocompromised due to disease or medication

Design outcomes

Primary

MeasureTime frame
To analyse immunometabolic pathways in AMs of healthy volunteers after “ex vivo” exposure to respiratory pathogens or components thereof using an integrative approach.

Secondary

MeasureTime frame
1. To obtain exploratory data on the composition and diversity of the lung microbiome. 2. To utilize Optical Coherence Tomography (OCT) and Confocal Laser Endomicroscopy (CLE) to visualize in vivo the healthy alveolar compartment and airway wall layers and compare this to airway wall histology.

Contacts

Public ContactLiza Pereverzeva

Amsterdam UMC, location AMC

e.pereverzeva@amsterdamumc.nl+31205666378

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)